Synthetic 1,3,6-Tri-O-Galloyl-α-D-Glucose Mimics the Hippo Pathway Inhibitor VT107 in Suppressing Concanavalin A-Induced Inflammation in Human Glioblastoma Cells

Angélique Sabaoth Konan, Rosalie Zilinski, Mirolla Tadrous, Alain Zgheib, Roger Gaudreault, Borhane Annabi · 2025

Read Synthetic 1,3,6-Tri-O-Galloyl-α-D-Glucose Mimics the Hippo Pathway Inhibitor VT107 in Suppressing Concanavalin A-Induced Inflammation in Human Glioblastoma Cells by Angélique Sabaoth Konan, Rosalie Zilinski, Mirolla Tadrous, Alain Zgheib, Roger Gaudreault, Borhane Annabi (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12724242.txt.

Description

Angélique Sabaoth Konan and co-authors test a plant-derived compound against inflammation inside brain tumor cells. Glioblastoma, the most aggressive adult brain tumor, thrives in an inflamed setting that helps it invade and resist treatment. The compound, a galloyl glucose from a medicinal tree fruit, was compared with drugs that block the Hippo growth pathway.

A plant lectin was used to stir inflammation in tumor cells, switching on two classic alarm pathways. The compound calmed both, much like the strongest drug in the comparison. It also cut the activation of an enzyme that helps tumors spread, and lowered a long list of inflammatory messengers. The authors argue the compound attacks on two fronts, inflammation and invasion, through the Hippo pathway. They pitch it as a candidate worth developing against this stubborn cancer.

Catalog record

CREATORAngélique Sabaoth Konan, Rosalie Zilinski, Mirolla Tadrous, Alain Zgheib, Roger Gaudreault, Borhane Annabi
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE33 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12724242

Browse the full library · About the Tower of Babel